OM

Opaleye Management Portfolio holdings

AUM $494M
1-Year Est. Return 68.17%
This Quarter Est. Return
1 Year Est. Return
+68.17%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$681M
AUM Growth
-$84.8M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
74
New
Increased
Reduced
Closed

Top Buys

1
+$36M
2
+$12.1M
3
+$11M
4
KROS icon
Keros Therapeutics
KROS
+$9.69M
5
MGNX icon
MacroGenics
MGNX
+$9.41M

Top Sells

1
+$41.5M
2
+$21.7M
3
+$20.2M
4
CRDF icon
Cardiff Oncology
CRDF
+$10.1M
5
KALV icon
KalVista Pharmaceuticals
KALV
+$8.93M

Sector Composition

1 Healthcare 98.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$7.85M 1.15%
903
-7
27
$7.78M 1.14%
341,950
+19,750
28
$7.69M 1.13%
297,000
+37,000
29
$7.49M 1.1%
+467,000
30
$7.07M 1.04%
357,800
+22,600
31
$7.01M 1.03%
+225,000
32
$6.3M 0.93%
166,667
+146,827
33
$6.11M 0.9%
835,000
+776,200
34
$5.94M 0.87%
320,926
+96,826
35
$5.74M 0.84%
193,750
36
$5.44M 0.8%
365,000
37
$5.34M 0.78%
77,800
38
$5.33M 0.78%
576,000
-1,086,500
39
$5.22M 0.77%
2,000,000
40
$5.21M 0.77%
1,937
+159
41
$5.14M 0.76%
249,800
-432,700
42
$5.1M 0.75%
5,880
43
$4.41M 0.65%
376,900
+95,613
44
$4.24M 0.62%
71,120
+320
45
$3.05M 0.45%
55,067
+26,067
46
$2.88M 0.42%
+241,300
47
$2.87M 0.42%
+188,000
48
$2.87M 0.42%
341,300
-316,200
49
$2.6M 0.38%
151,139
+75,760
50
$1.71M 0.25%
25,000
-89,000
1
2
3